Hemacell Perfusion Inc is categorized under Commercial Medical Research in Silver Spring, MD and active since 2005.
Hemacell Perfusion Inc was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Sherman Lazrus at the company’s headquarters by writing to 13308 Tamarack Road, Silver Spring, Maryland MD 20904 or by phoning (301) 442-6750. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hemacell Perfusion Inc |
| Contact Person: | Sherman Lazrus |
| Address: | 13308 Tamarack Road, Silver Spring, Maryland 20904 |
| Phone Number: | (301) 442-6750 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Hemacell Perfusion Inc was started in 2005 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sherman Lazrus for inquiries that concern Hemacell Perfusion Inc by calling the company number (301) 442-6750, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Hemacell Perfusion Inc can be found at the coordinates 39.073393,-76.981741 as well as the street address 13308 Tamarack Road in Silver Spring, Maryland 20904.
For its online presence, you may visit Hemacell Perfusion Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.